Abstract Details
|
Amie L. Hiller, MD
PRESENTER |
The institution of Dr. Hiller has received research support from Admas Pharmaceuticals. |
| Joseph F. Quinn, MD, FAAN (OHSU Neurology) | Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to AAN interests or activities. |
| Peter T. Schmidt, PhD | No disclosure on file |